Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rosetta Genomics Ltd.

www.rosettagenomics.com

Latest From Rosetta Genomics Ltd.

Device/Diagnostics Quarterly Deal-Making Statistics, Q4 2017

Device fundraising during the fourth quarter totaled $2.6 billion, making it the strongest quarter of the year. Q4 M&A activity reached $3.9 billion, higher than Q3's $3.4 billion, but still one of the lowest quarters of the year. Both fourth quarter diagnostics financings and M&As hit an all-year low of $622 million, and $2.8 million, respectively.

Deals Market Intelligence

Global Molecular Diagnostics Market To Reach $7.3B By 2019

The global molecular diagnostics market will grow by $2.4 billion over the next five years according to a global market report from Medtech Insight. Major factors contributing to the healthy growth of this market include advances in technology, as well as the growing understanding of the human genome, pharmacogenomics and the relationship between genes and disease/infection.

Medical Device Innovation

Deals In Depth: April 2015

Bristol is trying to build off of Eliquis momentum, signing a cardiovascular gene therapy deal with uniQure; Celgene capitalized on build-to-buy model and exercised option for Quanticel. Biopharma financing was down by almost $3 billion, while device fundraising was slightly up.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, May 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Research/Analytical, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Rosetta Genomics Ltd.
  • Senior Management
  • Ron Kalfus, CFO
    Eti Meiri, PhD, VP, R&D
    Douglas Sites, EVP, Sales & Mktg.
  • Contact Info
  • Rosetta Genomics Ltd.
    Phone: (972) 73 222 0700
    10 Plaut St.
    P.O. Box 4059 Rehovot, 76706
    Israel
UsernamePublicRestriction

Register